Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

FDMTFDMT
9 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in 4D MOLECULAR THERAPEUTICS IN

Schonfeld Strategic Advisors LLC holds 407,470 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $5.4M as of 2026-Q2. The position was increased (+303.0% shares). FDMT represents 0.0% of Schonfeld Strategic Advisors LLC's portfolio.

Current Value

$5.4M

Current Shares

407,470

Total Value Change

+$5.2M

Total Shares Change

+378,170

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
407,470
+303.0%
$5.4M0.0%$13.30
44
2026-Q1
Decreased
101,110
-37.6%
$941,3320.0%$8.46
0
2025-Q4
Decreased
161,982
-9.6%
$1.2M0.0%$7.58
0
2025-Q3
New
179,075
-
$1.6M0.0%$8.35
35
2024-Q3
Exited
0
-100.0%
$00.0%$10.83
0
2024-Q2
New
14,273
-
$299,5890.0%$20.99
32
2022-Q4
Exited
0
-100.0%
$00.0%$22.21
0
2022-Q3
Decreased
11,100
-62.1%
$89,0000.0%$8.22
0
2022-Q2
New
29,300
-
$205,0000.0%$7.27
32

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used